Stem Cells Market Is Estimated To Witness High Growth Owing To Advanced Therapies

 

Stem Cells Market
Stem Cells Market

The Stem Cells Market is estimated to be valued at Us$ 12.9 Bn or Mn in 2023 and is expected to exhibit a CAGR Of 9.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:


Stem cells are cells that have the ability to differentiate into specialized cells and can divide to produce more stem cells. They have wide range of therapeutic applications such as treating diseases like cancer, blood disorders, diabetes, and cardiac disorders. With increasing prevalence of chronic diseases, stem cell therapy offers promising treatment for various incurable diseases.

Market key trends:


Stem cell therapy has emerged as a potential treatment for various incurable diseases. One of the major trends in the stem cell market is the increasing research on using stem cells for advanced regenerative therapies. Numerous clinical trials are being conducted to evaluate stem cell efficacy in treatments of diseases like Parkinson's, Alzheimer's, diabetes and heart disease. Researchers are also working on developing suitable techniques for isolation, characterization and differentiation of stem cells into specialized cells. Furthermore, development of new stem cell banking techniques catering to long term preservation of stem cells is also contributing to the market growth over the forecast period.

Porter's Analysis


Threat of new entrants: New players can enter the stem cells market with relative ease as the required investment is moderate. However, established players have significant competitive advantages in terms of brand recognition, access to distribution channels and patents.

Bargaining power of buyers: The bargaining power of buyers is moderate. However, pricing pressure mounts as buyers have many options to choose from due to the presence of several stem cell companies.

Bargaining power of suppliers: Suppliers have moderate bargaining power due to the availability of differentiated product offerings by different suppliers. However, switching costs are low.
Threat of new substitutes: Substitutes pose a moderate threat as innovative products are continuously entering the market.

Competitive rivalry: Fierce due to technological advancements and strong competition among key players.

SWOT Analysis


Strength: High growth opportunities due to wide applications in regenerative medicine. Increasing investments in research and development activities.

Weakness: Ethical issues associated with the use of embryonic stem cells. High costs associated with research and development.

Opportunity: Rising geriatric population driving demand for stem cell therapies. Increasing support from governments worldwide.

Threats: Stringent regulatory framework. Risk of failure or rejection of stem cell transplantation.

Key Takeaways


The global Stem Cells Market size was valued at US$ 12.9 Bn in 2023 and is expected to reach US$ 58.2 Bn by 2030, expanding at a CAGR of 9.1% during the forecast period. Increasing prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases and rising investments in stem cell research are the key factors propelling market growth.

Regionally, North America dominated the global market and accounted for around 35% of the total market share in 2023. This is attributed to the growing stem cell banking facilities and rising government funding for stem cell research in the region. Asia Pacific is anticipated to be the fastest growing market during the forecast period owing to rising medical tourism, increasing healthcare expenditure and growing geriatric population.

Key players operating in the stem cells market are Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Biotricity, Lineage Cell Therapeutics, Inc., BrainStorm Cell Limited., CIRM, Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company), Takara Bio Inc., Cellular Engineering Technologies., Cytori Therapeutics Inc., and STEMCELL Technologies. Major players are focusing on strategic collaborations and acquisitions to strengthen their market position.


Read More : https://www.newswirestats.com/the-emerging-prospects-of-stem-cells-market/

Comments

Post a Comment

Popular posts from this blog

The Promising Neuroregeneration Therapy Market Will Grow At Highest Pace Owing To Growing Prevalence Of Neurodegenerative Diseases

Image
  Neuroregeneration Therapy Market Neuroregeneration therapy aims to reinstate nerve function lost through injury or disease. Some of the key advantages of these therapies include facilitating nerve regeneration to restore lost neural connections and reducing demyelination leading to improved nerve conduction. The therapies are finding increasing use in treating chronic conditions like Alzheimer's disease, Parkinson's disease and spinal cord injuries. The global Neuroregeneration Therapy Market is estimated to be valued at US$ 13.45 Billion in 2024 and is expected to exhibit a CAGR Of 16% over the forecast period 2024 To 2030 . Key players operating in the neuroregeneration therapy are Boeing, General Atomics, Israel Aerospace Industries Ltd, Northrop Grumman and Lockheed Martin Corporation. Key Takeaways Key players operating in the neuroregeneration therapy are focusing on developing new therapies through collaborations and acquisitions. For instance, in 2023 Boeing acqu...
Read more

The Global Idiopathic Pulmonary Fibrosis Market Growth Accelerated By Increasing Prevalence Of Idiopathic Pulmonary Fibrosis

Image
  Idiopathic Pulmonary Fibrosis Market Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible form of lung disease that causes scarring (fibrosis) of the lungs leading to stiffness and breathing difficulty. The key products in the IPF market include antibiotics, antifibrotics, oxygen therapy, lung transplantations, and physical therapy. These products play a vital role in reducing the deterioration of lung functioning and improving the quality of life in IPF patients. The global Idiopathic Pulmonary Fibrosis Market is estimated to be valued at Us$ 4825.57 Bn in 2024 and is expected to exhibit a CAGR Of 5.1% over the forecast period 2024 To 2031 , as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends driving the growth of the idiopathic pulmonary fibrosis market is the increasing prevalence of IPF across the globe. As per several studies, the prevalence of IPF has increased rapidly over the past ...
Read more

Space Planning Software Is Estimated To Witness High Growth Owing To Opportunity Of Increasing Demand For Space Optimization

Image
  Space Planning Software Market Space planning software is extensively used for space management, floor planning, space analysis, and cad services by various industries including corporate offices, healthcare facilities, educational institutions, and others. Space planning software helps in efficient layout planning, space utilization analysis, and facility management. It assists organizations in optimally allocating available space and analyzing various space planning scenarios. The global Space Planning Software Market is estimated to be valued at Us$ 967.43 Mn in 2023 and is expected to exhibit a CAGR Of 13.% over the forecast period 2023 To 2030 , as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The increasing demand for space optimization across industries is expected to drive the growth of space planning software market during the forecast period. Space planning software aids organizations in optimally planning available space ...
Read more